|Day Low/High||2,550.00 / 2,600.00|
|52 Wk Low/High||2,020.00 / 2,614.00|
Who's afraid of the big, bad Fed? Not Wall Street. Not anymore.
Stocks rocket higher on Tuesday as the fears over rate hikes that have plagued Wall Street for nearly a week begin to fade.
Oil, takeovers, tech, new-home sales -- all that and more drive stocks higher.
Monsanto (MON) stock is advancing on Tuesday afternoon as the company said it is open to deal talks with Bayer (BAYRY) but views its current $62 billion offer as 'inadequate.'
TheStreet highlights 3 stocks pushing the basic materials sector higher today.
Monsanto Company (NYSE: MON) today announced that its Board of Directors unanimously views the Bayer AG proposal as incomplete and financially inadequate, but is open to continued and constructive conversations to assess...
Investors are skeptical about the possible $62 billion combination, but the agricultural biotechnology company offers long-term potential, regardless.
Monsanto (MON) stock is climbing on Monday morning as the company will reportedly reject Bayer’s (BAYRY) $62 billion acquisition bid and seek a higher price.
Bayer says there's logic behind its $62 billion bid for the agricultural company. Analysts are not so sure.
Bayer spells out the logic behind its bid for the agricultural giant, citing the creation of an 'innovation powerhouse.'
Wall Street weighed the odds of a June rate hike, and the uncertainty left markets paralyzed for much of Monday's session.
The Federal Reserve remains in focus on Monday with speculation over a June rate hike leading to choppy trading.
Monsanto rises and Tribune Publishing sinks on separate merger bids.
German company Bayer offers a 37% premium to its St. Louis target's undisturbed share price.
Monsanto (MON) stock is advancing on Monday morning after Bayer (BAYRY) offered to buy the company for $62 billion in cash.
Monsanto (MON) and Bayer (BAYRY) don't have a sense of the current regulatory environment, Jim Cramer says.
Monsanto formally received a $62 billion takeover bid from Bayer which is valued at $122 a share.
Stocks struggle for direction on Monday morning as the possibility of a rate hike in June continues to loom large over Wall Street.
Trade-Ideas LLC identified Monsanto (MON) as an unusual social activity candidate
There's no way Bayer's potential takeover of Monsanto can survive heightened government opposition to deals perceived as curbing competition, says TheStreet's Jim Cramer.
U.S. stocks opened mixed on Monday as investors feared a sooner-than-excepted Fed rate hike.
Bayer offered to acquire Monsanto for $62 billion on Monday, a deal one analyst called a 'necessity.'
Stock futures are narrowly mixed on Monday morning as the possibility of a June rate hike looms large over Wall Street.
The bears' arguments aren't enough to kill the positive price action.
U.S. stock futures are rising slightly on Monday while European stocks trade mixed as data points to further evidence of subdued growth in the eurozone.
Bayer declines as it confirms a rights issue is on the agenda if a $62 billion takeover run at Monsanto succeeds.
Doug Kass shares his thoughts on how to navigate. He remains anticipatory.
There are lots of stocks still working in this market, and Cramer tells you which ones.
A higher probability the Federal Reserve could implement another rate hike in June sends shares sharply lower on Thursday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.